ストックスクリーナーアプリを入手
389.09
1.11%
-4.35
プレマーケット:
388.09
-1.00
-0.26%
Elevance Health Inc (ELV) 最新ニュース
AE1P Bond Profile — Key Metrics - TradingView
Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run - Yahoo Finance
Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis
Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Inc Stock Price Live, Charts & News - The Economic Times
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool
AE1D Bond Profile — Key Metrics - TradingView
AE1J Bond Profile — Key Metrics - TradingView
Elevance Health President Acquires 1.9% More Stock - Moomoo
Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health director Peru buys $366,050 in company stock - Investing.com UK
Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare
Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget
Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo
Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's
Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa
Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet
What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool
Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan
Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa
Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com Australia
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com Nigeria
Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo
Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo
Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404 - Moomoo
Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Sahm
Elevance Health Chairman Increases Stock Holdings - Intellectia AI
Elevance Health stock holds near earnings context - ad-hoc-news.de
Lobbying Update: $60,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Elevance Health earnings call: growth levers amid strain - The Globe and Mail
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
AE1N Bond Profile — Key Metrics - TradingView
RBC Lowers Price Target on Elevance Health to $424 From $439, Keeps Sector Perform Rating - Moomoo
Goldman Sachs Adjusts Price Target on Elevance Health to $395 From $370, Maintains Neutral Rating - Moomoo
Guggenheim Adjusts Price Target on Elevance Health to $455 From $399, Maintains Buy Rating - Moomoo
Wells Fargo Adjusts Price Target on Elevance Health to $473 From $492, Maintains Overweight Rating - Moomoo
Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says - marketscreener.com
Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance - TIKR.com
Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive - Yahoo Finance
The Medicaid Problem Weighing On Elevance Health Stock - Trefis
Baird Adjusts Price Target on Elevance Health to $393 From $331, Maintains Neutral Rating - marketscreener.com
1.94%
1.71%
大文字化:
|
ボリューム (24 時間):